MENU
AMPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products... Show more

A.I. Advisor
published Earnings

AMPH is expected to report earnings to rise 64.62% to 69 cents per share on August 10

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q2'26
Est.
$0.69
Q1'26
Missed
by $0.30
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.11
The last earnings report on May 07 showed earnings per share of 41 cents, missing the estimate of 72 cents. With 750.28K shares outstanding, the current market capitalization sits at 870.39M.
View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1976
Web
https://www.amphastar.com